Tradestie Institutional Equity Comparison Engine
SYK vs MDT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MDT Overall Edge
MDT Captures Institutional Edge (2โ2 Pillars ยท 6โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Medtronic plc (MDT) driven by superior Valuation, Momentum & Technical while SYK counters with relative strength in Growth & Margin, Options & Structure. Fundamentally, SYK trades at 19.0x Forward P/E with 24.0% operating margin (+7.6% YoY revenue) versus MDT at 17.0x Forward P/E and 20.1% operating margin (+13.7% YoY). In options structure, SYK sits in SURGE (5th %ile IV; Dealer Gamma Walls on Pro) against MDT sits in CONSOLIDATION (12th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
MDT
SYK 19.0x vs MDT 17.0x Fwd P/E
Growth & Margin Winner
SYK
Op Margin 24.0% vs 20.1% ยท YoY +7.6% vs +13.7%
Momentum & Technical Winner
MDT
1Y -16.8% vs +7.5% ยท 52W Pos 36% vs 91%
Options & Structure Winner
SYK
SURGE (5th %ile IV) vs CONSOLIDATION (12th %ile IV)
SYK
NYSE
Stryker Corporation
Surgical & Medical Instruments & Apparatus
$310.79
+0.37% 1D
Market Cap
$118.9B
1M Return
+5.47%
1Y Return
-16.77%
Forward P/E
19.0x
Unified AI Score
46.5 / 100
HOLD
Tech 37.0
Fund 49.0
Flow 58.0
Mom 60.0
MDT
NYSE
Medtronic plc
Electromedical & Electrotherapeutic Apparatus
$103.38
+0.5% 1D
Market Cap
$129.2B
1M Return
+9.1%
1Y Return
+7.53%
Forward P/E
17.0x
Unified AI Score
45.8 / 100
HOLD
Tech 22.0
Fund 46.0
Flow 69.0
Mom 46.5
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SYK -16.77%
MDT +7.53%
Spread: +24.3 pp (MDT Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SYK Revenue | MDT Revenue | SYK Op. Margin | MDT Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $14.9B | $30.6B | 18.2% | 20.5% | MDT |
| FY2020 | $14.3B | $28.9B | 15.5% | 16.6% | MDT |
| FY2021 | $17.1B | $30.1B | 15.1% | 14.9% | SYK |
| FY2022 | $18.4B | $31.7B | 15.4% | 18.2% | MDT |
| FY2023 | $20.5B | $31.2B | 19.0% | 17.6% | SYK |
| FY2024 | $22.6B | $32.4B | 16.3% | 15.9% | SYK |
| FY2025 | $25.1B | $33.5B | 19.5% | 17.8% | SYK |
| FY2026 | N/A | $36.4B | N/A | 17.8% | MDT |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SYK | MDT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $118.9B | $129.2B | Larger Scale | MDT |
| Trailing P/E Ratio Valuation | 33.3x | 24.8x | Lower Multiple | MDT |
| Forward P/E Ratio Valuation | 19.0x | 17.0x | Lower Multiple | MDT |
| Revenue Growth (YoY) Growth | +7.6% | +13.7% | Higher Growth | MDT |
| Operating Margin (TTM) Profitability | 24.0% | 20.1% | Higher Margin | SYK |
| Net Profit Margin Profitability | 13.8% | 13.9% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | 16.0% | 10.7% | Higher ROE | SYK |
| 52-Week Range Position Momentum | 36% ($267โ$389) | 91% ($73โ$106) | Stronger Trend | MDT |
| Beta / 30D Volatility Risk Regime | 0.22ฮฒ ยท 50% Vol | 0.15ฮฒ ยท 33% Vol | Lower Realized Risk | MDT |
| Unified Institutional Score Composite Signal | 46.5 / 100 (HOLD) | 45.8 / 100 (HOLD) | Higher Composite | SYK |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SYK vs MDT Buy Guide
SYK
SURGE
8d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
5th %ile
IV Regime
Compressed (<25th %ile)
MDT
CONSOLIDATION
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
12th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SYK nor MDT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.